Bayer Investing In Indonesia On Growth Prospects
This article was originally published in PharmAsia News
German pharmaceutical giant Bayer AG is investing EUR8.1 million to expand its drug manufacturing plant in Indonesia, with the aim of producing 50 million packs of medicines by 2020, its Indonesia chief said.
You may also be interested in...
A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.
An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.
Indonesia’s national health insurance operator is seeking an increase in premiums as it struggles with deficits amid soaring claims within the system.